NASDAQ: TXG
10x Genomics Inc Stock Ownership - Who owns 10x Genomics?

Insider buying vs selling

Have 10x Genomics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Serge SaxonovCEO2026-11-1031,000$62.90
$1.95MSell
Serge SaxonovCEO2026-09-221,000$78.23
$78.23kSell
Serge SaxonovCEO2026-09-229,300$80.90
$752.40kSell
Shehnaaz SulimanDirector2026-09-221,325$80.82
$107.08kSell
Shehnaaz SulimanDirector2026-09-22614$79.51
$48.82kSell
Shehnaaz SulimanDirector2026-09-22292$78.20
$22.83kSell
Serge SaxonovCEO2026-09-222,800$82.37
$230.62kSell
Serge SaxonovCEO2026-09-229,900$81.83
$810.07kSell
Serge SaxonovCEO2026-09-222,000$79.62
$159.24kSell
Shehnaaz SulimanDirector2026-09-221,222$82.28
$100.54kSell

1 of 6

TXG insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TXG insiders and whales buy or sell their stock.

TXG Shareholders

What type of owners hold 10x Genomics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Paladin Capital Management LLC4.27%5,617,583$316.27MInsider
Bryan E. Roberts3.30%4,336,630$244.15MInsider
Softbank Vision Fund Aiv M2 LP2.92%3,836,232$215.98MInsider
Venrock Associates VI LP1.55%2,037,825$114.73MInsider
Serge Saxonov0.88%1,162,537$65.45MInsider
Foresite Capital Management I LLC0.39%514,883$28.99MInsider
Benjamin J. Hindson0.37%488,182$27.48MInsider
John R. Stuelpnagel0.25%328,436$18.49MInsider
Adam Taich0.24%316,344$17.81MInsider
Mathai Mammen0.14%180,259$10.15MInsider

1 of 3

TXG vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TXG0.10%14.74%Net SellingNet Selling
HQY0.11%66.62%Net SellingNet Selling
HNGE0.08%5.44%Net SellingNet Selling
DOCS0.06%12.73%Net SellingNet Selling
WAY0.11%67.55%Net SellingNet Selling

10x Genomics Stock Ownership FAQ

Who owns 10x Genomics?

10x Genomics (NASDAQ: TXG) is owned by 0.10% institutional shareholders, 14.74% 10x Genomics insiders, and 85.16% retail investors. Paladin Capital Management LLC is the largest individual 10x Genomics shareholder, owning 5.62M shares representing 4.27% of the company. Paladin Capital Management LLC's 10x Genomics shares are currently valued at $320.60M.

If you're new to stock investing, here's how to buy 10x Genomics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.